Chemotherapy News and Research

Latest Chemotherapy News and Research

Association health plans: A favorite GOP approach to coverage poised for comeback

Not even 24 hours after the latest "repeal and replace" proposal ran out of steam, Sen. Rand Paul (R-Ky.) ignited a new round of health policy speculation by predicting, during a cable news interview, impending Trump administration action on a longtime Republican go-to idea: association health plans.

6 Oct 2017

New research can help develop better chemotherapy treatments for pancreatic cancer

Tal Danino, a professor at the Data Science Institute, is conducting research that could help scientists combat the most lethal of cancers: pancreatic cancer.

6 Oct 2017

Study finds underutilization of sperm banking by at-risk patients with cancer

A comprehensive study of adolescent and young adult cancer patients found just 43.8 percent of those at risk for infertility banked sperm prior to cancer therapy, suggesting that patients might benefit from efforts to increase awareness and understanding of the option.

5 Oct 2017

Gene therapy effectively stabilizes progression of cerebral adrenoleukodystrophy, trial reveals

In a recent clinical trial, a gene therapy to treat cerebral adrenoleukodystrophy (CALD) -- a neurodegenerative disease that typically claims young boys' lives within 10 years of diagnosis -- effectively stabilized the disease's progression in 88 percent of patients, researchers from the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Massachusetts General Hospital report today.

4 Oct 2017

Gene targets for triple negative breast cancers resistant to chemotherapy found

Researchers have finally found the genetic targets that could be used for treatment and development of new drugs in patients who are resistant to chemotherapy. These patients who are resistant to chemotherapy are most likely to have triple negative breast cancer which is the most aggressive form of breast cancer. The study appeared in the latest issue of the journal Cell Metabolism.

4 Oct 2017

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

A 30 year old Australian woman presented to the doctors with numerous small lumps under her arms for around two weeks. When one of the nodes were put under the microscope, the doctors found pigments from tattoo ink that she’d got 15 years back.

4 Oct 2017

New test identifies antibiotic-resistant bacteria in 30 minutes

The discovery of antibiotics in the early part of the 20th century changed modern medicine. Simple infections that previously killed people became easy to treat. Antibiotics' ability to stave off infections made possible routine surgeries, organ transplants, and chemotherapy for the treatment of cancer.

4 Oct 2017

Blood test for HPV could help identify cancer patients suitable for lower treatment doses

A blood test for the human papillomavirus, or HPV, may help researchers forecast whether patients with throat cancer linked to the sexually transmitted virus will respond to treatment, according to preliminary findings from the University of North Carolina Lineberger Comprehensive Cancer Center.

4 Oct 2017

Novel agents appear to halt growth and progression of Ewing sarcoma

When combined with an already FDA-approved chemotherapy, a novel agent developed by researchers at Georgetown Lombardi Comprehensive Cancer Center, appears to halt the ability of Ewing sarcoma to grow and progress.

4 Oct 2017

Research uncovers potential targets for treatment of triple negative breast cancer

Research led by Dr. Carlos Arteaga, Director of the Harold C. Simmons Comprehensive Cancer Center, has identified potential targets for treatment of triple negative breast cancer, the most aggressive form of breast cancer.

3 Oct 2017

Researchers identify new cancer-causing pathway behind most aggressive type of leukemia

A team led by Massachusetts General Hospital (MGH) investigators has identified a new cancer-causing pathway behind most cases of an aggressive type of leukemia, findings that could lead to new targeted treatment approaches.

3 Oct 2017

Researchers look for ways to prevent chemotherapy-induced cognitive impairment

Of the 14 million cancer survivors in the United States, a significant number experience a serious side effect called chemotherapy-induced cognitive impairment (CICI). While easily recognized, little is known about the etiology of this condition, also known informally as "chemo brain."

3 Oct 2017

FDA approves Verzenio for advanced metastatic breast cancer

The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.

2 Oct 2017

Benefits of Biomarkers in Colorectal Cancer Treatment

Biomarkers fall into different categories: diagnostic biomarkers, are used to identify a disease; prognostic biomarkers, help clinicians to determine, for example, whether you're more likely to die or have problems with a disease; and there are some that can be used to inform treatment, to determine whether one therapy would be more successful than another.

2 Oct 2017

Research findings can lead to new treatment for patients with fatal glandular cancer

A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon.

28 Sep 2017

Plant substance shows inhibitory effects on cancer stem cells

The plant Ambrosia arborescens grows at a high elevation in large parts of South America, and is traditionally used as a medicinal plant. The researchers have isolated the sesquiterpene lactone damsin from the plant and studied its effect on cancer stem cells in three different breast cancer cell lines.

27 Sep 2017

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.

27 Sep 2017

Chemotherapy News and Research

Latest Chemotherapy News and Research

Association health plans: A favorite GOP approach to coverage poised for comeback

New research can help develop better chemotherapy treatments for pancreatic cancer

Study finds underutilization of sperm banking by at-risk patients with cancer

Gene therapy effectively stabilizes progression of cerebral adrenoleukodystrophy, trial reveals

Gene targets for triple negative breast cancers resistant to chemotherapy found

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

New test identifies antibiotic-resistant bacteria in 30 minutes

Blood test for HPV could help identify cancer patients suitable for lower treatment doses

Novel agents appear to halt growth and progression of Ewing sarcoma

Research uncovers potential targets for treatment of triple negative breast cancer

Researchers identify new cancer-causing pathway behind most aggressive type of leukemia

Researchers look for ways to prevent chemotherapy-induced cognitive impairment

FDA approves Verzenio for advanced metastatic breast cancer

Benefits of Biomarkers in Colorectal Cancer Treatment

Research findings can lead to new treatment for patients with fatal glandular cancer

Plant substance shows inhibitory effects on cancer stem cells

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Trial identifies genetic fault that affects treatment response in leukemia patients

Drug combination produces synergistic effect against growth of triple-negative breast cancer

Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in